Target intelligence / Profile preview

Alpha-1-B glycoprotein (A1BG)

Target
A1BG
Molecular classification
Other, Immunoglobulin superfamily domain containing, Plasma glycoprotein
01

Overview

Alpha-1-B glycoprotein is a secreted plasma protein in humans encoded by the A1BG gene. It is composed of 495 amino acids with a molecular weight of about 54 kDa and exhibits sequence and structural similarity to immunoglobulin superfamily proteins, containing four or five immunoglobulin-like domains[1][2][3][5]. Despite extensive study, its precise biological function remains unclear. It binds to cysteine-rich secretory protein 3 (CRISP-3) in plasma, suggesting a protective role against potential CRISP-3 toxicity[1][3]. High A1BG expression has been found in liver, with trace levels in other tissues such as blood, pancreas, and brain[1]. Clinically, A1BG is overexpressed in the pancreatic juice of patients with pancreatic ductal adenocarcinoma, and urinary fragments serve as biomarkers for steroid-resistant nephrotic syndrome[1][3]. Its aberrant expression and processing have also been linked to inflammatory, renal, and autoimmune diseases, although it is not considered a direct therapeutic target or receptor[3][4].

Other names
Alpha-1B-glycoproteinA1BGAlpha-1-B glycoproteinA1BABGGABHYST2477HEL-S-163pAepididymis secretory sperm binding protein Li 163pA
02

Biological functions

Unknown functionPlasma proteinProtein interaction (binds CRISP-3)Potential immune regulation
03

Disease associations

Cancer (overexpressed in pancreatic ductal adenocarcinoma)Autoimmune disease (implicated in rheumatoid arthritis)Renal disease (biomarker in steroid-resistant nephrotic syndrome)Cardiovascular disease (changes seen after myocardial infarction)Other (potential biomarker in several diseases)
04

Biomarkers

Pancreatic ductal adenocarcinoma (overexpression in pancreatic juice)Steroid-resistant nephrotic syndrome (urinary 13.8 kDa fragment)Hepatocellular carcinoma (expression regulation via antisense RNA)

Beyond the preview

Go deeper on Alpha-1-B glycoprotein (A1BG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1-B glycoprotein (A1BG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call